Multiple Sclerosis Clinical Trials

A listing of Multiple Sclerosis medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Cullman Alabama 35058

A clinical study for patients with Relapsing-Remitting Multiple Sclerosis

UPDATED

Cullman Alabama 35058

A clinical trial to evaluate treatments using ACTH and Placebo for patients with Multiple Sclerosis, Relapsing-Remitting

Birmingham Alabama 35209

A clinical trial seeking patients for a research study for the treatment of Relapsing Remitting Multiple Sclerosis

Birmingham Alabama 35209

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

View More ▼

Cullman Alabama 35058

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Cullman Alabama 35058

Patients are needed to participate in a clinical research study evaluating Teriflunomide HMR1726 and Placebo for the treatment of Multiple Sclerosis

Homewood Alabama 35209

A clinical research study for the treatment of Multiple Sclerosis

Homewood Alabama 35209

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Arizona

Center for Neurosciences
Tucson Arizona 85718

PASSAGE: Post Approval Safety Study Assessing Gilenya Experience

View More ▼

UPDATED

Phoenix Arizona 85018

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

UPDATED

Tucson Arizona 85704

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

Gilbert Arizona 85234

A clinical research study for the treatment of Multiple Sclerosis

Gilbert Arizona 85234

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Gilbert Arizona 85234

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Gilbert Arizona 85234

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Phoenix Arizona 85006

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix Arizona 85048

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix Arizona 85018

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Phoenix Arizona 85018

A clinical trial to evaluate treatments using Ublituximab and Placebo for patients with Multiple Sclerosis

Phoenix Arizona 85006

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Phoenix Arizona 85013

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Phoenix Arizona

Patients are needed to participate in a clinical research study evaluating Laquinimod and Placebo for the treatment of Primary Progressive Multiple Sclerosis

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson Arizona 85741

A clinical trial seeking patients for a research study for the treatment of Multiple Sclerosis

Tucson Arizona 85718

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Tucson Arizona 85704

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Tucson Arizona 85741

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson Arizona 85704

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

Tucson Arizona 85741

Patients are needed to participate in a clinical research study of MSDX Complex-1 Biomarker test to evaluate Relapsing Remitting Multiple Sclerosis

Arkansas

Jonesboro Arkansas 72401

Patients are needed to participate in a clinical research study evaluating Dimethyl Fumarate, Montelukast and Placebo for the treatment of Multiple Sclerosis

Little Rock Arkansas 72202

A clinical trial to evaluate treatments using Interferon beta-1a i.m. injections, Fingolimod oral capsules, Placebo oral capsule and Placebo i.m. injection for patients with Multiple Sclerosis

California

UPDATED

Berkeley California 94705

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

UPDATED

Loma Linda California 92354

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

UPDATED

Long Beach California 90806

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

UPDATED

San Diego California 92103

A clinical research study of ALKS 8700 for the treatment of Multiple Sclerosis (MS) (the EVOLVE-1 Study)

Berkeley California 94705

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

View More ▼

Carlsbad California 92011

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Carlsbad California 92011

A Phase 3 clinical study for patients with Relapsing Multiple Sclerosis

Carmichael California 95608

Patients are needed to participate in a clinical research study evaluating Dimethyl Fumarate, Montelukast and Placebo for the treatment of Multiple Sclerosis

Fresno California 93720

A clinical study for patients with Multiple Sclerosis

Fullerton California 92835

A clinical study for patients with Multiple Sclerosis

Fullerton California 92835

A clinical research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

Fullerton California 92835

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Fullerton California 92835

A Phase 3 clinical study for patients with Multiple Sclerosis, Relapsing-Remitting

Hanford California 93230

A clinical research study for the treatment of Multiple Sclerosis

Hanford California 93230

A clinical trial to evaluate treatments for patients with Multiple Sclerosis

Hanford California 93230

Patients are needed to participate in a clinical research study evaluating peginterferon β-1a for the treatment of Relapsing Forms of Multiple Sclerosis

La Jolla California 92037

A clinical research study for the treatment of Multiple Sclerosis, Relapsing-Remitting

La Jolla California 92037

Patients are needed to participate in a clinical research study evaluating Dimethyl Fumarate, Montelukast and Placebo for the treatment of Multiple Sclerosis